Skip to main content
Top
Published in: Cancer Causes & Control 7/2013

01-07-2013 | Original paper

A prospective cohort study of shift work and the risk of death from pancreatic cancer in Japanese men

Authors: Yingsong Lin, Junko Ueda, Kiyoko Yagyu, Michiko Kurosawa, Akiko Tamakoshi, Shogo Kikuchi

Published in: Cancer Causes & Control | Issue 7/2013

Login to get access

Abstract

Purpose

There is mounting evidence that shift work involving night work increases cancer risk. We examined the relationship between working rotating shifts and the risk of death from pancreatic cancer on the basis of data from the Japanese Collaborative Cohort Study (JACC Study).

Methods

The present analysis was restricted to 22,224 men who were 40–65 years of age at baseline (1988–1990) and who reported working full time or were self-employed in the JACC Study. The subjects were followed through 31 December 2009. Information on occupation and lifestyle factors was collected using a self-administered questionnaire. The Cox proportional hazards model was used to estimate the relative risk (RR) and 95 % confidence interval (CI) for the risk of death from pancreatic cancer in relation to shift work.

Results

During the follow-up period, 127 pancreatic cancer deaths were observed. Overall, we found no statistically significant increase in the risk of death from pancreatic cancer associated with rotating shift work. As compared to day-shift workers, the RRs were 0.83 (95 % CI 0.43–1.60) for rotating shift workers and 0.61 (95 % CI 0.22–1.60) for fixed night-shift workers, after adjustment for potential confounding factors. The multivariable-adjusted RR was 1.34 (95 % CI 0.66–2.75) among rotating shift workers in the analysis restricted to men who reported working full time at baseline.

Conclusions

Our data did not support the hypothesis that shift work is significantly associated with the risk of death from pancreatic cancer in this cohort of Japanese men.
Literature
1.
go back to reference Michaud DS (2004) Epidemiology of pancreatic cancer. Minerva Chir 59:99–111PubMed Michaud DS (2004) Epidemiology of pancreatic cancer. Minerva Chir 59:99–111PubMed
3.
go back to reference Dauchy RT, Blask DE, Sauer LA, Brainard GC, Krause JA (1999) Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism. Cancer Lett 144:131–136PubMedCrossRef Dauchy RT, Blask DE, Sauer LA, Brainard GC, Krause JA (1999) Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism. Cancer Lett 144:131–136PubMedCrossRef
4.
go back to reference Blask DE, Dauchy RT, Sauer LA, Krause JA, Brainard GC (2002) Light during darkness, melatonin suppression and cancer progression. Neuro Endocrinol Lett 23(Suppl 2):52–56PubMed Blask DE, Dauchy RT, Sauer LA, Krause JA, Brainard GC (2002) Light during darkness, melatonin suppression and cancer progression. Neuro Endocrinol Lett 23(Suppl 2):52–56PubMed
5.
go back to reference Filipski E, King VM, Li X, Granda TG, Mormont MC, Liu X, Claustrat B, Hastings MH, Lévi F (2002) Host circadian clock as a control point in tumor progression. J Natl Cancer Inst 94:690–697PubMedCrossRef Filipski E, King VM, Li X, Granda TG, Mormont MC, Liu X, Claustrat B, Hastings MH, Lévi F (2002) Host circadian clock as a control point in tumor progression. J Natl Cancer Inst 94:690–697PubMedCrossRef
6.
go back to reference O’Leary ES, Schoenfeld ER, Stevens RG, Kabat GC, Henderson K, Grimson R, Gammon MD, Leske MC (2006) Electromagnetic Fields and Breast Cancer on Long Island Study Group. Shift work, light at night, and breast cancer on Long Island. New York. Am J Epidemiol 164:358–366CrossRef O’Leary ES, Schoenfeld ER, Stevens RG, Kabat GC, Henderson K, Grimson R, Gammon MD, Leske MC (2006) Electromagnetic Fields and Breast Cancer on Long Island Study Group. Shift work, light at night, and breast cancer on Long Island. New York. Am J Epidemiol 164:358–366CrossRef
7.
go back to reference Kubo T, Ozasa K, Mikami K, Wakai K, Fujino Y, Watanabe Y, Miki T, Nakao M, Hayashi K, Suzuki K, Mori M, Washio M, Sakauchi F, Ito Y, Yoshimura T, Tamakoshi A (2006) Prospective cohort study of the risk of prostate cancer among rotating-shift workers: findings from the Japan collaborative cohort study. Am J Epidemiol 164:549–555PubMedCrossRef Kubo T, Ozasa K, Mikami K, Wakai K, Fujino Y, Watanabe Y, Miki T, Nakao M, Hayashi K, Suzuki K, Mori M, Washio M, Sakauchi F, Ito Y, Yoshimura T, Tamakoshi A (2006) Prospective cohort study of the risk of prostate cancer among rotating-shift workers: findings from the Japan collaborative cohort study. Am J Epidemiol 164:549–555PubMedCrossRef
8.
go back to reference Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Colditz GA (2001) Rotating night shifts and risk of breast cancer in women participating in the nurses’ health study. J Natl Cancer Inst 93:1563–1568PubMedCrossRef Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Colditz GA (2001) Rotating night shifts and risk of breast cancer in women participating in the nurses’ health study. J Natl Cancer Inst 93:1563–1568PubMedCrossRef
9.
go back to reference Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Fuchs CS, Colditz GA (2003) Night-shift work and risk of colorectal cancer in the Nurses’ Health study. J Natl Cancer Inst 95:825–828PubMedCrossRef Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Fuchs CS, Colditz GA (2003) Night-shift work and risk of colorectal cancer in the Nurses’ Health study. J Natl Cancer Inst 95:825–828PubMedCrossRef
10.
go back to reference Davis S, Mirick DK, Stevens RG (2001) Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 93:1557–1562PubMedCrossRef Davis S, Mirick DK, Stevens RG (2001) Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 93:1557–1562PubMedCrossRef
11.
go back to reference Pronk A, Ji BT, Shu XO, Xue S, Yang G, Li HL, Rothman N, Gao YT, Zheng W, Chow WH (2010) Night-shift work and breast cancer risk in a cohort of Chinese women. Am J Epidemiol 171:953–959PubMedCrossRef Pronk A, Ji BT, Shu XO, Xue S, Yang G, Li HL, Rothman N, Gao YT, Zheng W, Chow WH (2010) Night-shift work and breast cancer risk in a cohort of Chinese women. Am J Epidemiol 171:953–959PubMedCrossRef
12.
go back to reference Parent MÉ, El-Zein M, Rousseau MC, Pintos J, Siemiatycki J (2012) Night work and the risk of cancer among men. Am J Epidemiol 176:751–759PubMedCrossRef Parent MÉ, El-Zein M, Rousseau MC, Pintos J, Siemiatycki J (2012) Night work and the risk of cancer among men. Am J Epidemiol 176:751–759PubMedCrossRef
13.
go back to reference Poole EM, Schernhammer ES, Tworoger SS (2011) Rotating night shift work and risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev 20:934–938PubMedCrossRef Poole EM, Schernhammer ES, Tworoger SS (2011) Rotating night shift work and risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev 20:934–938PubMedCrossRef
14.
go back to reference Hansen J, Lassen CF (2012) Nested case-control study of night shift work and breast cancer risk among women in the Danish military. Occup Environ Med 69:551–556PubMedCrossRef Hansen J, Lassen CF (2012) Nested case-control study of night shift work and breast cancer risk among women in the Danish military. Occup Environ Med 69:551–556PubMedCrossRef
15.
go back to reference Hansen J, Stevens RG (2012) Case-control study of shift-work and breast cancer risk in Danish nurses: impact of shift systems. Eur J Cancer 48:1722–1729PubMedCrossRef Hansen J, Stevens RG (2012) Case-control study of shift-work and breast cancer risk in Danish nurses: impact of shift systems. Eur J Cancer 48:1722–1729PubMedCrossRef
16.
go back to reference IARC (2010) IARC monographs on the evaluation of carcinogenic risks to humans; volume 98, shift work, painting and fire-fighting. International Agency for Research on Cancer, Lyon IARC (2010) IARC monographs on the evaluation of carcinogenic risks to humans; volume 98, shift work, painting and fire-fighting. International Agency for Research on Cancer, Lyon
17.
go back to reference Davis S, Mirick DK (2006) Circadian disruption, shift work and risk of cancer: a summary of the evidence and studies in Seattle. Cancer Causes Control 17:539–545PubMedCrossRef Davis S, Mirick DK (2006) Circadian disruption, shift work and risk of cancer: a summary of the evidence and studies in Seattle. Cancer Causes Control 17:539–545PubMedCrossRef
18.
go back to reference Haus E, Smolensky M (2006) Biological clocks and shift work: circadian dysregulation and potential long-term effects. Cancer Causes Control 17:489–500PubMedCrossRef Haus E, Smolensky M (2006) Biological clocks and shift work: circadian dysregulation and potential long-term effects. Cancer Causes Control 17:489–500PubMedCrossRef
19.
go back to reference Chu LW, Zhu Y, Yu K, Zheng T, Chokkalingam AP, Stanczyk FZ, Gao YT, Hsing AW (2008) Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I. Cancer Epidemiol Biomarkers Prev 17:3268–3273PubMedCrossRef Chu LW, Zhu Y, Yu K, Zheng T, Chokkalingam AP, Stanczyk FZ, Gao YT, Hsing AW (2008) Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I. Cancer Epidemiol Biomarkers Prev 17:3268–3273PubMedCrossRef
20.
go back to reference Zhu Y, Brown HN, Zhang Y, Stevens RG, Zheng T (2005) Period3 structural variation: a circadian biomarker with breast cancer in young women. Cancer Epidemiol Biomarkers Prev 14:268–270PubMed Zhu Y, Brown HN, Zhang Y, Stevens RG, Zheng T (2005) Period3 structural variation: a circadian biomarker with breast cancer in young women. Cancer Epidemiol Biomarkers Prev 14:268–270PubMed
Metadata
Title
A prospective cohort study of shift work and the risk of death from pancreatic cancer in Japanese men
Authors
Yingsong Lin
Junko Ueda
Kiyoko Yagyu
Michiko Kurosawa
Akiko Tamakoshi
Shogo Kikuchi
Publication date
01-07-2013
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 7/2013
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-013-0214-0

Other articles of this Issue 7/2013

Cancer Causes & Control 7/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine